AAAAAA
Results: 1-25/73
Authors:
LAGNEAUX L
DELFORGE L
BERNIER M
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., TGF-BETA ACTIVITY AND EXPRESSION OF ITS RECEPTORS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 31(1-2), 1998, pp. 99
Authors:
TRENSCHEL R
BERNIER M
DELFORGE A
MASSY M
DEHEMRICOURT EL
MAEREVOET M
BADJOU R
STRYCKMANS P
BRON D
Citation: R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 325-352
Authors:
BLEIBERG H
DUCHATEAU J
MBON JBN
GERARD B
BRON D
DEBUSSCHER L
STRYCKMANS P
Citation: H. Bleiberg et al., INCREASED INCIDENCE OF LYMPHOMAS AND CARCINOMAS IN PATIENTS WITH CELIAC-DISEASE, European journal of cancer, 34(4), 1998, pp. 592-593
Authors:
MATEO V
LAGNEAUX L
BRON D
SARFATI M
Citation: V. Mateo et al., INDUCTION OF APOPTOSIS IN B-CELLS FROM LYMPHOCYTIC-LEUKEMIA (B-CLLS) BY CD47, The FASEB journal, 12(5), 1998, pp. 6263-6263
Authors:
GUGLIELMI C
GOMEZ F
PHILIP T
HAGENBEEK A
MARTELLI M
SEBBAN C
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
Citation: C. Guglielmi et al., TIME TO RELAPSE HAS PROGNOSTIC VALUE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ENROLLED ONTO THE PARMA TRIAL, Journal of clinical oncology, 16(10), 1998, pp. 3264-3269
Authors:
TIRELLI U
ERRANTE D
VANGLABBEKE M
TEODOROVIC I
KLUINNELEMANS JC
THOMAS J
BRON D
ROSTI G
SOMERS R
ZAGONEL V
NOORDIJK EM
Citation: U. Tirelli et al., CHOP IS THE STANDARD REGIMEN IN PATIENTS GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE WITH INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 16(1), 1998, pp. 27-34
Authors:
DEBRUYN C
DELFORGE A
BRON D
Citation: C. Debruyn et al., STEM-CELL FACTOR AND INTERLEUKIN-3 RECEPTOR EXPRESSION ON CD34(-) CELLS FROM UMBILICAL-CORD BLOOD AND MOBILIZED PERIPHERAL-BLOOD()CD38(+) AND CD34(+)CD38(), Experimental hematology, 26(8), 1998, pp. 197-197
Authors:
MEULEMAN N
DEBRUYNE JM
MAEREVOET M
RIZOPOULO H
ACKERMANS S
BRON D
Citation: N. Meuleman et al., INCIDENCE OF CMV INFECTION AND CMV DISEASE IN 100 ALLOGENIC TRANSPLANTED PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT, Bone marrow transplantation, 21, 1998, pp. 489-489
Authors:
MEULEMAN N
MAEREVOET M
CRENIER L
CROMBEZ P
AOUN M
BRON D
Citation: N. Meuleman et al., EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA WITH AZTREONAM TEICOPLANIN IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - EXPERIENCE IN ONE SINGLE-CENTER, Bone marrow transplantation, 21, 1998, pp. 541-541
Authors:
PHILIP T
GOMEZ F
GUGLIELMI C
HAGENBEEK A
SEBBAN C
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
Citation: T. Philip et al., LONG-TERM OUTCOME OF RELAPSED NON-HODGKINS-LYMPHOMA (NHL) PATIENTS INCLUDED IN THE PARMA TRIAL - INCIDENCE OF LATE RELAPSES, LONG-TERM TOXICITY AND IMPACT OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) AT RELAPSE, Bone marrow transplantation, 21, 1998, pp. 595-595
Authors:
GUGLIELMI C
GOMEZ F
HAGENBEEK A
SEBBAN C
MARTELLI M
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
PHILIP T
Citation: C. Guglielmi et al., TIME TO RELAPSE HAS PROGNOSTIC VALUE IN AGGRESSIVE LYMPHOMA ENROLLED IN THE PARMA TRIAL AT FIRST RELAPSE, Bone marrow transplantation, 21, 1998, pp. 623-623
Authors:
ROUFOSSE C
LESPAGNARD L
SALES F
BRON D
DARGENT JL
Citation: C. Roufosse et al., LANGERHANS CELL HISTIOCYTOSIS ASSOCIATED WITH SIMULTANEOUS LYMPHOCYTEPREDOMINANCE HODGKINS-DISEASE AND MALIGNANT-MELANOMA, Human pathology, 29(2), 1998, pp. 200-201
Authors:
BRON D
DELFORGE A
BOSMANS E
BRUGGEMAN C
SNOECK R
DECLERCQ E
STRYCKMANS P
LAGNEAUX L
Citation: D. Bron et al., DYSREGULATION OF CYTOKINE PRODUCTION BY BONE-MARROW STROMAL CELLS AFTER EXPOSURE TO HUMAN CYTOMEGALOVIRUS (HUCMV) OR RECOMBINANT PROTEINS OF HUCMV, British Journal of Haematology, 102(1), 1998, pp. 18-19
Authors:
DEBRUYN C
DELFORGE A
BRON D
Citation: C. Debruyn et al., CHARACTERIZATION OF CD34(-) CELLS FROM UMBILICAL-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER STIMULATION BY SCF+IL-3()CD38(+) AND CD34(+)CD38(), British Journal of Haematology, 102(1), 1998, pp. 25-25
Authors:
THEUNISSEN K
BIGANZOLI L
MAERTENS J
ZACHEE P
PARIDAENS R
VANOOSTEROM A
BRON D
PICCART M
BOOGAERTS M
Citation: K. Theunissen et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION AFTER DOCETAXEL AND LENOGRASTIM IN PATIENTS WITH METASTATIC BREAST-CANCER, British Journal of Haematology, 102(1), 1998, pp. 74-74
Authors:
VARADY E
BRON D
MOLNAR Z
SCHNEIDER T
ROSTA A
Citation: E. Varady et al., 2ND MALIGNANCY IN HODGKINS-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 120-120
Authors:
BRON D
MEULEMAN N
DEBRUYNE JM
MAEREVOET M
RIZOPOULO H
STRYCKMANS P
Citation: D. Bron et al., CMV INFECTION AND DISEASE IN 100 ALLOGENEIC BMT PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 208-209
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC LEUKEMIC B-CELLS BUT NOT NORMAL B-CELLS ARE RESCUED FROM APOPTOSIS BY CONTACT WITH NORMAL BONE-MARROW STROMAL CELLS, Blood, 91(7), 1998, pp. 2387-2396
Authors:
DEBRUYN C
DELFORGE A
BRON D
BERNIER M
MASSY M
DEHEMPTINNE D
STRYCKMANS P
Citation: C. Debruyn et al., EX-VIVO EXPANSION OF CD34- CORD-BLOOD CELLS(CD38), Journal of hematotherapy, 6(2), 1997, pp. 93-102
Authors:
MEERWALDT JH
CARDE P
SOMERS R
THOMAS J
KLUINNELEMANS JC
BRON D
NOORDIJK EM
COSSET JM
BIJNENS L
TEODOROVIC I
HAGENBEEK A
Citation: Jh. Meerwaldt et al., PERSISTENT IMPROVED RESULTS AFTER ADDING VINCRISTINE AND BLEOMYCIN TOA CYCLOPHOSPHAMIDE HYDROXORUBICIN/VM-26/PREDNISONE COMBINATION (CHVMP) IN STAGE III-IV INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA/, Annals of oncology, 8, 1997, pp. 67-70
Authors:
DEBRUYN C
DELFORGE A
BRON D
STRYCKMANS P
Citation: C. Debruyn et al., CELL-CYCLE STATUS OF CD34(-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER CYTOKINE STIMULATION() SUBPOPULATIONS FROM UMBILICAL), Experimental hematology, 25(8), 1997, pp. 256-256
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) B-LYMPHOCYTES BUT NOT NORMAL B-LYMPHOCYTES ARE RESCUED FROM APOPTOSIS BY CONTACT WITH BONE-MARROW STROMAL CELLS, Experimental hematology, 25(8), 1997, pp. 469-469
Authors:
TRENSCHEL R
BERNIER M
STRYCKMANS P
VERHEST A
BADJOU R
CROMBEZ P
BRON D
Citation: R. Trenschel et al., COMPLETE REMISSION FOLLOWING DONOR PBSC AFTER LOW-DOSE CYTARABINE CHEMOTHERAPY FOR EARLY RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 381-383
Authors:
LAGNEAUX L
DELFORGE A
BRON D
MASSY M
BERNIER M
STRYCKMANS P
Citation: L. Lagneaux et al., HETEROGENOUS RESPONSE OF B-LYMPHOCYTES TO TRANSFORMING GROWTH-FACTOR-BETA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH THE EXPRESSION OF TGF-BETA RECEPTORS, British Journal of Haematology, 97(3), 1997, pp. 612-620
Authors:
DEBRUYN C
BRON D
STRYCKMANS P
DELFORGE A
Citation: C. Debruyn et al., CHARACTERIZATION OF CD34(-) CELLS FROM UMBILICAL-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER STIMULATION BY SCF+IL-3()CD38(+) AND OF CD34(+)CD38(), Blood, 90(10), 1997, pp. 3355-3355